載入...
Immune checkpoint inhibitors: new strategies to checkmate cancer
Immune checkpoint inhibitors (ICIs) targeting cytotoxic T lymphocyte‐associated protein‐4 (CTLA‐4) or programmed cell death protein 1 (PD‐1) receptors have demonstrated remarkable efficacy in subsets of patients with malignant disease. This emerging treatment modality holds great promise for future...
Na minha lista:
| 發表在: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5758374/ https://ncbi.nlm.nih.gov/pubmed/29139554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13081 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|